Patent 7910331 was granted and assigned to Schering on March, 2011 by the United States Patent and Trademark Office.
CTLA-8 related antigens from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said antigens. Methods of using said reagents and diagnostic kits are also provided.